These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31670958)

  • 21. Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Guan D; Chen F; Xiong L; Tang F; Faridoon ; Qiu Y; Zhang N; Gong L; Li J; Lan L; Huang W
    J Med Chem; 2018 Jan; 61(1):286-304. PubMed ID: 29243921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
    Dilworth TJ; Leonard SN; Vilay AM; Mercier RC
    Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
    Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
    Adv Exp Med Biol; 2013; 788():125-32. PubMed ID: 23835969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
    Leonard SN; Rybak MJ
    J Antimicrob Chemother; 2009 Jan; 63(1):155-60. PubMed ID: 18984644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
    Camargo IL; Neoh HM; Cui L; Hiramatsu K
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4289-99. PubMed ID: 18824611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface Ligand Density of Antibiotic-Nanoparticle Conjugates Enhances Target Avidity and Membrane Permeabilization of Vancomycin-Resistant Bacteria.
    Hassan MM; Ranzoni A; Phetsang W; Blaskovich MA; Cooper MA
    Bioconjug Chem; 2017 Feb; 28(2):353-361. PubMed ID: 27959504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of heterogeneous vancomycin-intermediate Staphylococcus aureus correlated with increase of vancomycin MIC.
    Chen H; Liu Y; Sun W; Chen M; Wang H
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):301-3. PubMed ID: 21856109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany.
    Bierbaum G; Fuchs K; Lenz W; Szekat C; Sahl HG
    Eur J Clin Microbiol Infect Dis; 1999 Oct; 18(10):691-6. PubMed ID: 10584894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining the FtsZ-Targeting Prodrug TXA709 and the Cephalosporin Cefdinir Confers Synergy and Reduces the Frequency of Resistance in Methicillin-Resistant Staphylococcus aureus.
    Kaul M; Mark L; Parhi AK; LaVoie EJ; Pilch DS
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4290-6. PubMed ID: 27161635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence of vancomycin-resistant Staphylococcus aureus in the oral cavity of patients with dental caries.
    Vellappally S; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Alqahtani A; Dalati MHN; Anil S; Khan AA; Harikrishna Varma PR
    Acta Microbiol Immunol Hung; 2017 Sep; 64(3):343-351. PubMed ID: 28889756
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Mohammadi-Berenjestanaki H; Khori V; Shirzad-Aski H; Ghaemi EA
    Microb Drug Resist; 2020 Mar; 26(3):218-226. PubMed ID: 31424323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study].
    Çıkman A; Aydın M; Gülhan B; Parlak M; Gültepe B; Kalaycı Y; Bayındır Bilmen F; Solmaz S; Özekinci T
    Mikrobiyol Bul; 2015 Apr; 49(2):240-8. PubMed ID: 26167824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains.
    Clin Infect Dis; ; . PubMed ID: 16323115
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.